Immunovant Inc (IMVT)
Immunovant Announces Pricing of $550 Million Common Stock Financing
Guardant Health Inc (GH)
Guardant Health et le Policlinico Gemelli lancent un service interne de tests de biopsie liquide en Italie
Zealand Pharma A/S (company was delisted NASDAQ) (ZEAL)
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
Guardant Health Inc (GH)
Guardant Health en Policlinico Gemelli lanceren eigen testdienst voor vloeibare biopsieën in Italië
Addex Therapeutics Ltd (ADXN)
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
Innate Pharma S.A. (IPHA)
Innate Pharma - Innate Pharma Releases Its 2026 Financial Calendar
Zealand Pharma A/S (company was delisted NASDAQ) (ZEAL)
Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
Zealand Pharma A/S (company was delisted NASDAQ) (ZEAL)
OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
Guardant Health Inc (GH)
Guardant Health und Policlinico Gemelli starten internen Flüssigbiopsie-Testdienst in Italien
Guardant Health Inc (GH)
Guardant Health y el Policlínico Gemelli lanzan un servicio interno de biopsia líquida en Italia